Call For Papers for Special Session: 12th IEEE International Conference on BioInformatics and BioEngineering

11 - 13 November 2011, Larnaca, Cyprus.
Call For Papers for Special Session on Computational solutions to large-scale data management and analysis in translational, personalized and predictive medicine.
Medicine is undergoing a revolution that is transforming the nature of healthcare from reactive to preventive. The changes are catalyzed by a new systems approach to disease that focuses on integrated diagnosis, treatment and prevention of disease in individuals. This is expected to replace our current mode of medicine over the coming years with a personalized and predictive treatment. While the goal is clear, the path is fraught with challenges.

Our success in addressing these challenges depends on our ability to properly interpret the large-scale, high-dimensional data sets that are generated by modern technologies, since it is becoming increasingly clear that a comprehensive analysis of biological systems requires the integration of all fingerprints of cellular function: genome sequence, maps of gene expression, protein expression, metabolic output, and in vivo enzymatic expression (activity). This need for integration is especially clear in the case of complex, multifactorial diseases, such as cancer.

At the same time the Virtual Physiological Human (VPH) framework aims to define methods and technologies that once fully established will enable the investigation of the human body as a whole, eventually leading to a better healthcare system that offers personalized care solutions, more holistic approach to medicine and a preventative approach to the treatment of disease. Although consensus exists about what the fundamental tools are (integration of highthroughput data from several biologic scales, high-definition imaging, and computational modeling), no such consensus exists as to what are the most promising scientific approaches in responding to these challenges.

A growing awareness is found that, despite significant technological advances in various domains of relevance, fundamental obstacles separate systems biology from clinical applications. Bridging these gaps will require a focused and concerted effort in addressing various questions, such as:

  • What defines systems medicine as a discipline?
  • What should it seek to accomplish?
  • How to develop optimal frameworks for large-scale data sharing?
  • How to exploit data from hospital information systems, EHRs and PHRs and how to curate these data?
  • How should knowledge from disparate sources be assembled into ontologies relevant to systems medicine?
  • How are multiscale data to be synthesized by corresponding multiscale models?
  • How should models be represented, stored, managed and shared?
  • What is the burden of proof that such models are valid and predictive of clinically relevant outcomes?

Furthermore, because of the necessary multiscale nature of the models bridging embedded levels of organization from molecules, organelles, cells, tissues, organs, and all the way to individuals, environmental factors, populations, and ecosystems, systems medicine aims to discover and select the key factors at each level and integrate them into models of translational relevance, which include measurable readouts and clinical predictions.

The Special Session will build on experiences as well as technological and scientific developments stemming from some flagship projects funded by the EU under the FP7 framework programme aiming to bring together researches working in the fields of infrastructures and technologies for integrative biomedical research, ICT for predictive and translational medicine and the VPH at large.

In addition the Special Session invites original research work in all aspects of Cancer Informatics with a focus on revealing progress, and challenges in some of core domains that support the vision of predictive and personalised medicine in the domain of cancer.

Organisers:

  • Prof. Manolis Tsiknakis, TEI Crete and FORTH
  • Dr. Kostas Marias, FORTH
  • Dr. Vangelis Sakkalis, FORTH
  • Prof. Dr. Norbert Graf, University of Saarland
  • Dr. Anca Bucur, Philips Research, Eindhoven, NL
  • Prof Constantinos S. Pattichis, University of Cyprus

Projects:
The Special session will draw upon experiences form some flagship EU funded projects such as:

Important Dates:
Paper Submission Deadline: July 15, 2012
Paper Notification: August 15, 2012
Camera Ready Paper: September 8, 2012

For further information and registration, please visit:
http://bibe2012.cs.ucy.ac.cy

About IEEE International Conference on BioInformatics and BioEngineering
The annual IEEE International Conference on Bioinformatics and Bioengineering cover complementary disciplines that hold great promise for the advancement of research and development in complex medical and biological systems, agriculture, environment, public health, drug design, and so on. Research and development in these two areas are impacting the science and technology of fields such as medicine, food production, forensics, etc. by advancing fundamental concepts in molecular biology and in medicine, by helping us understand living organisms at multiple levels, by developing innovative implants and bio-prosthetics, and by improving tools and techniques for the detection, prevention and treatment of 1diseases. The BIBE series provides a common platform for the cross fertilization of ideas, and to help shape knowledge and scientific achievements by bridging these two very important and complementary disciplines into an interactive and attractive forum. Keeping this objective in mind, BIBE solicits original contributions in the following non exclusive lists of areas.

Most Popular Now

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...